In April 2025, Colossal Biosciences announced the birth of three animals it called dire wolves: two males born in October 2024, and a female born in January 2025, named Romulus, Remus, and Khaleesi. The announcement generated significant media coverage and was described by the company as the world's first de-extinction.
What Colossal actually built is more precisely described as gene-edited gray wolves. Their scientists extracted ancient DNA from a 13,000-year-old dire wolf tooth and a 72,000-year-old ear bone, identified 20 genetic variants across 14 genes that distinguish dire wolf from gray wolf, and edited those variants into gray wolf cells via CRISPR. The edited cells were cloned via somatic cell nuclear transfer and carried to term by domestic dog surrogates.
The result is gray wolves with 20 targeted edits. Colossal's own chief science officer, Beth Shapiro, confirmed this framing publicly: "Our animals are grey wolves with 20 edits that are cloned." The edited variants affect coat color and some morphological traits, giving the animals a pale coat and larger build. They do not carry the broader Aenocyon genome, and the IUCN Species Survival Commission's Canid Specialist Group formally declared them neither dire wolves nor functional proxies under IUCN guidelines.
None of this makes the work unimportant. Colossal set a technical record for precision germline edits in a healthy vertebrate, advanced cloning methodology using minimally invasive blood-draw cell sourcing, and produced a peer-reviewed paleogenomics dataset that improves the ancient genome reconstruction methods the whole field depends on. The underlying science is real and it matters.
The debate worth paying attention to is not whether the animals look like dire wolves, but what the project's framing reveals about the state of de-extinction science and public communication. The gap between "gray wolves with 20 edits" and "the world's first de-extinct animal" is large enough that scientists from multiple institutions objected publicly. MIT Technology Review named the announcement one of the eight worst technology flops of 2025, specifically citing the scientific community's response.
For Rewild Genomics, the Colossal project is instructive on two levels. First, the paleogenomics work is directly useful. The improved ancient genome reconstruction methods and the published Aenocyon dataset are resources we build on. Second, the project illustrates precisely what an open-science approach is for: when methodology is proprietary and claims are made before peer review, there is no external check on the gap between what was achieved and how it is described.
Our approach is different. We publish methods, make data available, and do not describe work as something it is not. The dire wolf is one of the hardest genomic targets in this field. That is not a reason to avoid it. It is a reason to be honest about where the science is and what remains to be done.